Grants for Businesses in EU
4 opportunities
Prevention and mitigation of misuse of synthetic biology for bioterrorism purposes
→Expected Outcome: Project results are expected to contribute to all of the following expected outcomes: Increased understanding of European policy makers, research community, biotech companies, and relevant security practitioners of the threat of bioterrorism and of synthetic biology, including a thorough lawful analysis of what needs to be monitored in this context, what needs to be regulated and how; Awareness raised within the related scientific community how research in synthetic biology can be used for malicious purposes. Scope: The rising threat of bioterrorism is driven by recent scientific advancements, notably by growing accessibility of synthetic biology, genetic engineering, related commercial services and public databases, which in turn enhance their obtainability to non-state actors and individuals with malicious intentions. The proliferation of do-it-yourself biohacking and community laboratories, including gene editing and sequencing technology, dropping costs of equipment and increased simplicity of use may inadvertently facilitate knowledge and skills dissemination about biological threats and open new pathways for bioterrorism. Challenges in detection,…
Grant$3.5MCloses 2026-11-05EUResearchEuropean Film sales agent
→Objective: Expected results: Improvement in the trans-national distribution of recent non-national European films. Increase in the investment in the production, acquisition, promotion, theatrical and online distribution of non-national European films. Develop links between the production and distribution sector thus improving the competitive position of non-national European films. Description of the activities: There are two phases for the funded activities: 1. The generation of a potential fund which will be attributed according to the performance of the company on the European market. 2. The implementation of the action - the potential fund thus generated by each company must be reinvested in: -minimum guarantees or advances paid for the international sales rights on eligible non-national European films; -the promotion, marketing and advertising on the market of eligible non-national European films.
GrantCloses in 14 daysEUOtherOrganised crime and drug trafficking
→Expected Impact: In the long-term , the funding is expected to: have increased operational capacity of law enforcement and other security-oriented authorities to fight organised crime and drug production and trafficking, including an improved capability to trace and untangle complex money laundering schemes as well as illicit flows of goods. enhance risk assessments and risk awareness and resilience measures in view of anticipating, preventing and tackling organised crime and drug related crimes. have improved cross-border cooperation including with key third countries and information exchange (including where possible and applicable with the private sector) and sharing of challenges and good practices in fighting against organised crime. have improved detection, identification and referral of victims of crime in the context of cross-border operational actions, as well as improved protection of victims in criminal proceedings, in cooperation with civil society organisations. Expected Outcome: Projects should aim to achieve one or more of the following outcomes: increase understanding of the nature and modus operandi of criminal networks and key actors and enablers including in…
GrantCloses 2026-09-03EUProfessional ServicesI3-2026-INV1 - Interregional Innovation Investments Strand 1
→Expected Impact: FOR ALL THREE THEMATIC PRIORITIES: Expected impact at the closure of the project (non-exhaustive list): Innovative technologies tested and adopted by the market; Innovative solutions deployed improving businesses confidence, competences and means to digitalise and grow; Contribution to digitisation and health systems transformation, through various types of innovation and the supply of IT services; Uptake of technologically/economically reliable and viable solutions on the market; Deployment of new technologies fostering the growth of Europe’s manufacturing sector; Innovative technologies adopted by SMEs; Identification of possible sources of funding/funding mix, to cover the residual investment needs (public-private partnerships for the deployment of innovation, the collaboration with venture capitals, EIB group loans etc); Strengthening innovation diffusion channels; Reinforcing the capacity of regions to co-invest together, joining forces on common S3 investment priorities (interregional investments). Long-term impact (non-exhaustive list): Increased companies’ productivity and efficiency; Improved user-friendly, accessible and interoperable public…
GrantCloses 2026-11-12EUHealth